Expand SMMT Menu
SMMT MENU

SMMT Stock Posts


Unusual Option Volume

SMMT Summit Therapeutics17.48+0.07 (+0.4%)

Summit Therapeutics trades 5,892 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics17.22+1.37 (+8.6%)

Summit Therapeutics trades 4,641 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics15.84-0.18 (-1.1%)

Summit Therapeutics trades 16,522 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics15.74-1.13 (-6.7%)

Summit Therapeutics trades 9,185 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics17.36-0.78 (-4.3%)

Summit Therapeutics trades 4,336 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Unusual Option Volume

SMMT Summit Therapeutics17.54+0.39 (+2.3%)

Summit Therapeutics trades 2,421 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
View Details...
Load Earlier Posts
Market Data Delayed 15 Minutes